Pharmaceutical consumption in Poland
Poland: Pharmaceutical consumption was 175.6 Defined daily dose per 1 000 inhabitants per day in 2025. ▲ Rising
Pharmaceutical consumption in Poland, 2019–2025
Source: Organisation for Economic Co-operation and Development. Measured in Defined daily dose per 1 000 inhabitants per day.
Analysis
The most recent figure for pharmaceutical consumption in Poland is 175.6 Defined daily dose per 1 000 inhabitants per day, measured in 2025. That is the highest value across all 7 years on record.
Compared with earlier readings it is up 7.1% on the previous year and up 34.7% over ten years.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 130.4 Defined daily dose per 1 000 inhabitants per day | 130.4 Defined daily dose per 1 000 inhabitants per day | 130.4 Defined daily dose per 1 000 inhabitants per day | 1 |
| 2020s | 150.62 Defined daily dose per 1 000 inhabitants per day | 134.7 Defined daily dose per 1 000 inhabitants per day | 175.6 Defined daily dose per 1 000 inhabitants per day | 6 |
Countries ranked near Poland
- 6 Greece 352.1 Defined daily dose per 1 000 inhabitants per day compare
- 7 New Zealand 351.1 Defined daily dose per 1 000 inhabitants per day compare
- 8 Norway 342.2 Defined daily dose per 1 000 inhabitants per day compare
- 9 Spain 320.8 Defined daily dose per 1 000 inhabitants per day compare
- 10 Sweden 315.3 Defined daily dose per 1 000 inhabitants per day compare
- 11 Portugal 311 Defined daily dose per 1 000 inhabitants per day compare
- 12 United Kingdom 308.8 Defined daily dose per 1 000 inhabitants per day compare
More health data for Poland
- Mortality, morbidity and welfare cost from exposure to 1.69 Per 1 000 inhabitants (2019)
- Life expectancy — Life expectancy difference -7.4 Years (2024)
- Life expectancy — Life expectancy difference 7.4 Years (2024)
- Life expectancy 78.5 Years (2024)
- Infant health: low birthweight 5.4 Percentage of live births (2024)
- Maternal and infant mortality — Perinatal mortality 3.7 Deaths per 1 000 births (2024)
- Healthcare coverage — Health insurance coverage 34,349 Persons (2025)
- Causes of mortality 408,504 Deaths (2024)
- Communicable diseases — Communicable disease incidence 163 Cases (2024)
- Hospital beds by function of healthcare 6.27 Per 1 000 inhabitants (2024)
Frequently asked questions
- What is pharmaceutical consumption in Poland?
- Pharmaceutical consumption in Poland was 175.6 Defined daily dose per 1 000 inhabitants per day in 2025, according to Organisation for Economic Co-operation and Development.
- What is the highest pharmaceutical consumption recorded in Poland?
- The highest recorded value was 175.6 Defined daily dose per 1 000 inhabitants per day in 2025.
- What is the lowest pharmaceutical consumption recorded in Poland?
- The lowest recorded value was 130.4 Defined daily dose per 1 000 inhabitants per day in 2019.
- How does Poland rank for pharmaceutical consumption?
- Poland ranks 9th out of 9 groups with data for 2025.
- Is pharmaceutical consumption rising or falling in Poland?
- Over the last ten years it is up 34.7%. The long-run trend across the full record is rising.
- Where does this Poland data come from?
- The figures come from Organisation for Economic Co-operation and Development, published as part of Pharmaceutical consumption. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under OECD Terms and Conditions (attribution required).
About this data
Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.